Paramyxovirus V protein interaction with the antiviral sensor LGP2 disrupts MDA5 signaling enhancement but is not relevant to LGP2- mediated RLR signaling inhibition

Journal of Virology

Volumn 88, Issue 14, 2014, Pages 8180-8188

  Rodriguez, Kenny R ^a   Horvath, Curt M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; LABORATORY OF GENETICS AND PHYSIOLOGY GENE 2 PROTEIN; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 PROTEIN; RIG I LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN V;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEASLES VIRUS; MOLECULAR RECOGNITION; NONHUMAN; PARAINFLUENZA VIRUS 5; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION;

CELL LINE; DEAD-BOX RNA HELICASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MEASLES VIRUS; PARAINFLUENZA VIRUS 5; PROTEIN BINDING; RNA HELICASES; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 84903906555     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00737-14     Document Type: Article

References (39)

1. Ramos HJ, Gale MJ. 2011. RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr. Opin. Virol. 1:167-176. http://dx.doi.org/10.1016/j.coviro.2011.04.004.
2. Bruns AM, Horvath CM. 2012. Activation of RIG-I-like receptor signal transduction. Crit. Rev. Biochem. Mol. Biol. 47:194-206. http://dx.doi.org/10.3109/10409238.2011.630974.
3. Gerlier D, Lyles DS. 2011. Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol. Mol. Biol. Rev. 75:468-490. http://dx.doi.org/10.1128/MMBR.00007-11.
4. Ramachandran A, Horvath CM. 2009. Paramyxovirus disruption of interferon signal transduction: STATus report. J. Interferon Cytokine Res. 29:531-537. http://dx.doi.org/10.1089/jir.2009.0070.
5. Goodbourn S, Randall RE. 2009. The regulation of type I interferon production by paramyxoviruses. J. Interferon Cytokine Res. 29:539-547. http://dx.doi.org/10.1089/jir.2009.0071.
6. Childs K, Stock N, Ross C, Andrejeva J, Hilton L, Skinner M, Randall RE, Goodbourn S. 2007. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190-200. http://dx.doi.org/10.1016/j.virol.2006.09.023.
7. Parisien J-P, Bamming D, Komuro A, Ramachandran A, Rodriguez JJ, Barber G, Wojahn RD, Horvath CM. 2009. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J. Virol. 83:7252-7260. http://dx.doi.org/10.1128/JVI.00153-09.
8. Ramachandran A, Horvath CM. 2010. Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference. J. Virol. 84: 11152-11163. http://dx.doi.org/10.1128/JVI.01375-10.
9. Andrejeva J, Childs K, Young D, Carlos T, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFNinducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U. S. A. 101:17264-17269. http://dx.doi.org/10.1073/pnas.0407639101.
10. Bamming D, Horvath CM. 2009. Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2. J. Biol. Chem. 284:9700-9712. http://dx.doi.org/10.1074 /jbc.M807365200.
11. Motz C, Schuhmann KM, Kirchhofer A, Moldt M, Witte G, Conzelmann K-K, Hopfner K-P. 2013. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 339: 690-693. http://dx.doi.org/10.1126/science.1230949.
12. Rodriguez KR, Horvath CM. 2013. Amino acid requirements for MDA5 and LGP2 recognition by paramyxovirus V proteins: a single arginine distinguishes MDA5 from RIG-I. J. Virol. 87:2974-2978. http://dx.doi.org/10.1128/JVI.02843-12.
13. Zhu Z, Zhang X, Wang G, Zheng H. 2014. The laboratory of genetics and physiology 2: emerging insights into the controversial functions of this RIG-I-like receptor. Biomed. Res. Int. 2014:960190. http://dx.doi.org/10.1155/2014/960190.
14. Komuro A, Horvath CM. 2006. RNA-and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J. Virol. 80:12332-12342. http://dx.doi.org/10.1128/JVI.01325-06.
15. Rothenfusser S, Goutagny N, DiPerna G, Gong M, Monks BG, Schoenemeyer A, Yamamoto M, Akira S, Fitzgerald KA. 2005. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175:5260-5268. http://dx.doi.org/10.4049/jimmunol.175.8.5260.
16. Saito T, Hirai R, Loo Y-M, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale MJ. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. U. S. A. 104:582-587. http://dx.doi.org/10.1073/pnas.0606699104.
17. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo Y-M, Gale MJ, Akira S, Yonehara S, Kato A, Fujita T. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175:2851-2858. http://dx.doi.org/10.4049/jimmunol.175.5.2851.
18. Komuro A, Bamming D, Horvath CM. 2008. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 43:350-358. http://dx.doi.org/10.1016/j.cyto.2008.07.011.
19. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O. 2010. LGP2 is a positive regulator of RIG-I-and MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. U. S. A. 107:1512-1517. http://dx.doi.org/10.1073 /pnas.0912986107.
20. Venkataraman T, Valdes M, Elsby R, Kakuta S, Caceres G, Saijo S, Iwakura Y, Barber GN. 2007. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178:6444-6455. http: //dx.doi.org/10.4049/jimmunol.178.10.6444.
21. Deddouche S, Goubau D, Rehwinkel J, Chakravarty P, Begum S, Maillard PV, Borg A, Matthews N, Feng Q, van Kuppeveld FJM, Reis e Sousa C. 2014. Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. eLife 3:e01535. http://dx.doi.org/10.7554 /eLife.01535.
22. Bruns AM, Pollpeter D, Hadizadeh N, Myong S, Marko JF, Horvath CM. 2013. ATP hydrolysis enhances RNA recognition and antiviral signal transduction by the innate immune sensor, laboratory of genetics and physiology 2 (LGP2). J. Biol. Chem. 288:938-946. http://dx.doi.org/10.1074/jbc.M112.424416.
23. Childs KS, Randall RE, Goodbourn S. 2013. LGP2 plays a critical role in sensitizing mda-5 to activation by double-stranded RNA. PLoS One 8:e64202-e64202. http://dx.doi.org/10.1371/journal.pone.0064202.
24. Childs KS, Randall RE, Goodbourn S. 2012. Paramyxovirus V proteins interact with the RNA helicase LGP2 to inhibit RIG-I-dependent interferon induction. J. Virol. 86:3411-3421. http://dx.doi.org/10.1128/JVI.06405-11.
25. Pippig DA, Hellmuth JC, Cui S, Kirchhofer A, Lammens K, Lammens A, Schmidt A, Rothenfusser S, Hopfner K-P. 2009. The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA. Nucleic Acids Res. 37:2014-2025. http://dx.doi.org/10.1093/nar/gkp059.
26. Gitlin L, Benoit L, Song C, Cella M, Gilfillan S, Holtzman MJ, Colonna M. 2010. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog. 6:e1000734. http://dx.doi.org/10.1371/journal.ppat.1000734.
27. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale MJ. 2008. Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 82:609-616. http://dx.doi.org/10.1128/JVI.01305-07.
28. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, Dermody TS, Fujita T, Akira S. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acidinducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205:1601-1610. http://dx.doi.org/10.1084/jem.20080091.
29. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh C-S, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
30. McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Virgin HW, Colonna M. 2008. MDA-5 recognition of a murine norovirus. PLoS Pathog. 4:e1000108. http://dx.doi.org/10.1371/journal.ppat.1000108.
31. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103:8459-8464. http: //dx.doi.org/10.1073/pnas.0603082103.
32. Strähle L, Marq J-B, Brini A, Hausmann S, Kolakofsky D, Garcin D. 2007. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. J. Virol. 81:12227-12237. http://dx.doi.org/10.1128/JVI.01300-07.
33. Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF. 2005. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus-and Toll-like receptor 3-triggered signaling pathways. J. Virol. 79: 6078-6088. http://dx.doi.org/10.1128/JVI.79.10.6078-6088.2005.
34. Johnston MD. 1981. The characteristics required for a Sendai virus preparation to induce high levels of interferon in human lymphoblastoid cells. J. Gen. Virol. 56:175-184. http://dx.doi.org/10.1099/0022-1317-56-1-175.
35. Strähle L, Garcin D, Kolakofsky D. 2006. Sendai virus defectiveinterfering genomes and the activation of interferon-beta. Virology 351: 101-111. http://dx.doi.org/10.1016/j.virol.2006.03.022.
36. Yount JS, Kraus TA, Horvath CM, Moran TM, López CB. 2006. A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. J. Immunol. 177:4503-4513. http://dx.doi.org/10.4049/jimmunol.177.7.4503.
37. Yount JS, Gitlin L, Moran TM, López CB. 2008. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J. Immunol. 180:4910-4918. http://dx.doi.org/10.4049 /jimmunol.180.7.4910.
38. Baum A, Sachidanandam R, García-Sastre A. 2010. Preference of RIG-I for short viralRNAmolecules in infected cells revealed by next-generation sequencing. Proc. Natl. Acad. Sci. U. S. A. 107:16303-16308. http://dx.doi.org/10.1073/pnas.1005077107.
39. Poole E, He B, Lamb RA, Randall RE, Goodbourn S. 2002. The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology 303:33-46. http://dx.doi.org/10.1006/viro.2002.1737.